Report - Nuevas estrategias en el tratamiento del cáncer de …2013/06/05 · BIG 2-06 / GSK EGF106708 A randomised, multicentre, open-label, phase III study of adyuvant lapatinib, trastuzumab,

Please pass captcha verification before submit form